U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07785180) titled 'A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy' on Aug. 20.
Brief Summary: The main goal of this study is to investigate the effectiveness and safety of chemotherapy agents in the treatment of participants with BPDCN and to provide comparator arm data to the prospective ELZONRIS registry study (STML-401-0521).
Study Start Date: Oct. 17, 2025
Study Type: OBSERVATIONAL
Condition:
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Intervention:
DRUG: Chemotherapy
Several chemotherapy regimens can be considered (acute myeloid leukemia-like, acute lymphocytic leukemia-like, lymphoma-like). The ch...